A federal perspective on the abuse of prescription stimulants

Psychiatric Annals

Volumn 35, Issue 3, 2005, Pages 260-263

  Clark, H Westley ^a   Bizzell, Anton C ^b  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b Center for Substance Abuse Treatment   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; NON PRESCRIPTION DRUG; PSYCHOSTIMULANT AGENT; SEDATIVE AGENT; TRANQUILIZER;

ADDICTION; CONTROL STRATEGY; DIAGNOSTIC PROCEDURE; DRUG ABUSE; DRUG MISUSE; DRUG OVERDOSE; HEALTH CARE ORGANIZATION; HEALTH SURVEY; HUMAN; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; RISK FACTOR; RISK REDUCTION; STATISTICAL SIGNIFICANCE; TOXICITY; UNITED STATES;

EID: 16244409299     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (4)

1. 2003 National Survey on Drug Use and Health. Rockville, MD: US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. Available at: http://www.oas.samhsa.gov/nhsda.htm#NHSDAinfo. Accessed February 15, 2005.
2. Parran TV Jr. Prescription drug abuse: A question of balance. Alcohol and Other Substance Abuse. 1997;81(4):253-978.
3. Methadone-Associated Mortality: Report of a National Assessment, May 8-9, 2003. Rockville, MD: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment; 2004. SAMHSA Publication No. 04-3904.
4. The President's National Drug Control Strategy. Office of National Drug Control Policy. March 2004. Available at: http://www.whitehousedrugpolicy.gov/ publications/policy/ndcs04/index.html. Accessed February 7, 2005.